Tikvah Management LLC

13F Portfolio Filings

Latest 13F report
Q2 2024 - Aug 12, 2024
Value $
$283M
Signature - Title
Lucas Prillaman - Director of Operations
Location
5970 Fairview Road, Suite 705, Charlotte, NC
Holdings Value
Quarter Holdings Value $ Bought Sold Net Top Holdings Form Type Date Filed
Q2 2024 25 $283M +$7.03M -$2.16M +$4.87M AMZN, GOOGL, BIO, PCOR, GOOG 13F-HR 8/12/2024, 01:13 PM
Q1 2024 22 $318M +$25.3M -$20.7M +$4.59M AMZN, BIO, GOOGL, PCOR, SPY 13F-HR 5/14/2024, 05:32 PM
Q4 2023 22 $291M +$19.2M -$24.8M -$5.61M AMZN, BIO, GOOGL, PCOR, AVDX 13F-HR 2/13/2024, 06:29 PM
Q3 2023 22 $279M +$1.02M -$7.49M -$6.47M AMZN, BIO, GOOGL, AVDX, PCOR 13F-HR 11/13/2023, 06:36 PM
Q2 2023 22 $294M +$30.7M -$2.39M +$28.3M AMZN, BIO, GOOGL, AVDX, PCOR 13F-HR 8/11/2023, 02:41 PM
Q1 2023 23 $243M +$12.6M +$12.6M BIO, AMZN, GOOGL, AVDX, PCOR 13F-HR 5/10/2023, 11:28 AM
Q4 2022 23 $209M +$13.6M -$3.94M +$9.64M BIO, AMZN, AVDX, GOOGL, SPY 13F-HR 2/6/2023, 01:47 PM
Q3 2022 23 $216M +$38.5M +$38.5M AMZN, BIO, GOOGL, AVDX, SPY 13F-HR 11/14/2022, 12:04 PM
Q2 2022 24 $232M +$45M -$399K +$44.6M BIO, AMZN, GOOGL, AVDX, SPY 13F-HR 8/12/2022, 05:56 PM
Q1 2022 23 $313M +$80.7M +$80.7M AMZN, BIO, GOOGL, AVDX, SLGC 13F-HR 5/16/2022, 02:13 PM
Q4 2021 21 $357M +$72.7M -$1.01M +$71.7M BIOB, AMZN, GOOGL, AVDX, SPY 13F-HR 2/14/2022, 09:46 AM
Q3 2021 21 $370M +$45.8M -$50.5M -$4.69M BIOB, AMZN, INOV, GOOGL, SMRT 13F-HR 11/12/2021, 11:30 AM
Q2 2021 18 $362M +$83M -$125M -$42M AMZN, BIOB, QADA, INOV, GOOGL 13F-HR 8/13/2021, 05:40 PM
Q1 2021 16 $357M +$1.64M -$25.2M -$23.6M BIO, QADA, AMZN, INOV, GOOGL 13F-HR 5/14/2021, 05:36 PM
Q4 2020 17 $359M +$3.15M -$8.54M -$5.4M BIO, AMZN, QADA, INOV, GOOGL 13F-HR 2/16/2021, 08:39 PM
Q3 2020 17 $324M +$2.76M -$26.7M -$23.9M BIO, AMZN, QADA, INOV, FARO 13F-HR 11/16/2020, 04:03 PM
Q2 2020 19 $327M +$15.7M +$15.7M AMZN, BIO, QADA, INOV, FARO 13F-HR 8/14/2020, 09:00 AM
Q1 2020 17 $253M +$2.19M -$73M -$70.8M AMZN, BIO, QADA, INOV, FARO 13F-HR 5/14/2020, 05:54 PM
Q4 2019 18 $387M +$3.68M +$3.68M BIO, QADA, AMZN, INOV, GOOG 13F-HR 2/13/2020, 12:23 PM
Q3 2019 19 $359M +$9.58M -$4.64M +$4.94M BIO, QADA, AMZN, INOV, GOOG 13F-HR 11/13/2019, 12:57 PM
Q2 2019 19 $352M +$42M +$42M AMZN, BIO, QADA, FARO, INOV 13F-HR 8/13/2019, 09:40 AM
Q1 2019 19 $301M +$8.51M -$1.24M +$7.27M AMZN, BIO, QADA, INOV, FARO 13F-HR 5/14/2019, 03:52 PM
Q4 2018 20 $282M +$27.2M -$8.58M +$18.6M AMZN, QADA, BIO, INOV, NATI 13F-HR 2/13/2019, 12:38 PM
Q3 2018 19 $335M +$5.86M -$16.2M -$10.3M QADA, AMZN, BIO, NATI, FARO 13F-HR 11/13/2018, 03:30 PM
Q2 2018 18 $319M -$20M -$20M QADA, AMZN, BIO, NATI, FARO 13F-HR 8/14/2018, 12:16 PM
Q1 2018 18 $325M +$61.4M +$61.4M AMZN, QADA, BIO, INDA, NATI 13F-HR 5/14/2018, 06:39 PM
Q4 2017 18 $249M +$1.82M -$3.85M -$2.03M QADA, BIO, AMZN, NATI, BRKA 13F-HR 2/13/2018, 05:15 PM
Q3 2017 19 $236M +$15.3M +$15.3M QADA, BIO, AMZN, NATI, INOV 13F-HR 11/13/2017, 06:11 PM
Q2 2017 18 $212M +$3.99M -$1.94K +$3.99M QADA, BIO, AMZN, NATI, BRKA 13F-HR 8/11/2017, 06:01 PM
Q1 2017 17 $191M +$10.3M -$15.5M -$5.15M BIO, QADA, AMZN, BRKA, NATI 13F-HR 5/12/2017, 01:12 PM
Q4 2016 18 $203M +$6.11M -$7.71M -$1.6M QADA, BIO, SPY, AMZN, BRKA 13F-HR 2/13/2017, 10:35 AM
Q3 2016 18 $192M +$18.7M +$18.7M QADA, BIO, AMZN, SPY, NATI 13F-HR 11/14/2016, 08:44 AM
Q2 2016 17 $171M +$2.31M -$7.94K +$2.3M SPY, QADA, BIO, AMZN, NATI 13F-HR 8/15/2016, 11:04 AM
Q1 2016 16 $180M +$12.7M -$6.07M +$6.67M QADA, SPY, NATI, BIO, AMZN 13F-HR 5/16/2016, 11:12 AM
Q4 2015 18 $191M +$32.9M +$32.9M SPY, QADA, NATI, BIO, AMZN 13F-HR 2/16/2016, 09:57 AM
Q3 2015 19 $180M +$2.86M -$4.62M -$1.75M QADA, SPY, NATI, BIO, AMZN 13F-HR 11/16/2015, 08:58 AM
Q2 2015 19 $189M +$7.07M -$4.89M +$2.18M SPY, QADA, NATI, BIO, NICE 13F-HR 8/14/2015, 10:57 AM
Q1 2015 19 $181M +$35.1M -$6.72M +$28.4M SPY, QADA, NATI, BRKA, NICE 13F-HR 5/15/2015, 11:00 AM
Q4 2014 16 $153M +$16M -$224K +$15.8M SPY, BRKA, NATI, NICE, BIO 13F-HR 2/17/2015, 09:06 AM
Q3 2014 16 $131M +$939K -$159K +$780K SPY, BRKA, NATI, BAC, GS Restatement 11/21/2014, 08:43 AM
Q2 2014 17 $142M +$21.5M -$54.2K +$21.4M SPY, NATI, BRKA, BIOB, NICE 13F-HR 8/14/2014, 11:03 AM
Q1 2014 17 $135M SPY, BRKA, BIO, NATI, BAC 13F-HR 5/15/2014, 11:00 AM